Penn Comprehensive Hemophilia & Thrombosis Program — Philadelphia, Pennsylvania

Penn Comprehensive Hemophilia & Thrombosis Program is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Penn Comprehensive Hemophilia & Thrombosis Program has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Disease.

Sponsors: Novo Nordisk A/S.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

• Jefferson University Physicians (JUP) - Jefferson Pulmonary
• Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania
• Thomas Jefferson University Hospital /ID# 232614
• Thomas Jefferson University Hospital;Medical Oncology
• Thomas Jefferson Memorial Hospital
• Fox Chase Temple Cancer Center - Temple University
• University of Pennsylania, Perelman School of Medicine
• Thomas Jefferson University_Philadelphia
• Thomas Jefferson University Hospital, Cardiovascular Associates
• Thomas Jefferson University Honickman Center
• Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital
• Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Comprehensive Hemophilia & Thrombosis Program?

Penn Comprehensive Hemophilia & Thrombosis Program has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Comprehensive Hemophilia & Thrombosis Program conducted?

Penn Comprehensive Hemophilia & Thrombosis Program has 1 clinical trials on record. Their work covers Sickle Cell Disease.

Is Penn Comprehensive Hemophilia & Thrombosis Program accredited by Crixeo Clinical Trials?

Penn Comprehensive Hemophilia & Thrombosis Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn Comprehensive Hemophilia & Thrombosis Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.